S85394 |
Eribulin (mesylate) |
源叶(MedMol) | 98% |
- 提示:详情请下载说明书。
- 产品描述: Eribulin Mesylate (E7389, B-1939, ER-086526,E7389 mesylate) 是海洋天然产物软海绵素 B 的类似物,是一种非紫杉烷完全合成的 微管 (microtubule)抑制剂
- 靶点: microtubule
- 体外研究: Eribulin Mesylate (1-100 nM; 72 h) inhibits cells proliferation of LM8 and Dunn cells. Eribulin Mesylate (10-50 nM; 12-72 h) increases early apoptosis significantly in LM8 cells. Eribulin Mesylate (10-50 nM; 12-72 h) induces G2/M arrest by 12 h treatment with at the dose of 50 nM, but not by long-term treatment (72 h) with 10 nM in LM8 cells. Eribulin Mesylate (1-10 nM; 16 h) induces morphological change and suppresses cell migration in a low concentration in LM8 cells
- 体内研究: Eribulin Mesylate reduces primary tumor growth and lung metastasis of osteosarcoma in mice
- 细胞实验: Cell lines: LM8 cells, Dunn cells Concentrations: 10 nM, 50 nM Incubation Time: 72 h Method: LM8 cells and Dunn cells are incubated with 0 nM, 10 nM, or 50 nM eribulin Mesylate for 12 h, 24 h, 48 h, or 72 h. And then cell proliferation, cell cycle and apoptosis are detected by flow cytometry analysis and immunofluorescence.
- 动物实验: Animal Models: 4-week-old C3H/HeN mice inoculated with LM8 cells Dosages: 1 mg/kg Administration: I.v.
- 参考文献:
1. Sarika Jain, Linda T Vahdat. Eribulin mesylate. Clin Cancer Res. 2011 Nov 1;17(21):6615-22. 2. Watanabe K, et al. Low-dose eribulin reduces lung metastasis of osteosarcoma in vitro and in vivo. Oncotarget. 2019 Jan 4;10(2):161-174.
- 溶解性: 10 mM in DMSO
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 1.211 ml 6.053 ml 12.107 ml 5 mM 0.242 ml 1.211 ml 2.421 ml 10 mM 0.121 ml 0.605 ml 1.211 ml 50 mM 0.024 ml 0.121 ml 0.242 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)